GARS1 and peripheral neuropathy: To understand whether a loss-of-function scenario is a plausible mechanism for PN-GlyRS, we first evaluated whether a substantial reduction of dGlyRS levels, which consequently reduces tRNAGly aminoacylation, is sufficient to inhibit protein synthesis and induce peripheral neuropathy-related phenotypes.